Vigil Neuroscience, Inc. (VIGL) - Stock Prices, Stock Peers & Analysis

Home
VIGL

Company Name	Vigil Neuroscience, Inc.
Symbol	VIGL
Currency	USD
Price	2.41
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	112,478,399
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	1.312 - 6.06
Industry	Biotechnology
Sector	Healthcare
CEO	Dr. Ivana Magovcevic-Liebisch J.D., Ph.D.
Website	https://www.vigilneuro.com

An error occurred while fetching data.

About Vigil Neuroscience, Inc.

Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed on myeloid cells 2 (TREM2)